ArticleInternational journal of transgender health2026
Pretreatment homocysteine and molecular endothelial risk in transgender women starting estrogen-based hormone therapy.
Daniele Tienforti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.